Fulgent Genetics, Inc. (FLGT)
19.45
-0.45
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
19.43
-0.02
(-0.10%)
Pre-Market: 20:00
Fulgent Genetics Total Liabilities (Quarterly) : 93.24M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.24M |
| March 31, 2026 | 112.22M |
| December 31, 2025 | 106.81M |
| September 30, 2025 | 93.81M |
| June 30, 2025 | 88.20M |
| March 31, 2025 | 82.97M |
| December 31, 2024 | 127.92M |
| September 30, 2024 | 98.86M |
| June 30, 2024 | 103.39M |
| March 31, 2024 | 103.24M |
| December 31, 2023 | 139.82M |
| September 30, 2023 | 96.56M |
| June 30, 2023 | 91.25M |
| March 31, 2023 | 107.85M |
| December 31, 2022 | 166.43M |
| September 30, 2022 | 124.38M |
| June 30, 2022 | 150.93M |
| March 31, 2022 | 152.63M |
| December 31, 2021 | 131.39M |
| September 30, 2021 | 160.22M |
| June 30, 2021 | 129.13M |
| March 31, 2021 | 197.52M |
| Date | Value |
|---|---|
| December 31, 2020 | 136.28M |
| September 30, 2020 | 60.36M |
| June 30, 2020 | 8.872M |
| March 31, 2020 | 7.953M |
| December 31, 2019 | 7.061M |
| September 30, 2019 | 6.619M |
| June 30, 2019 | 5.294M |
| March 31, 2019 | 5.691M |
| December 31, 2018 | 3.47M |
| September 30, 2018 | 2.266M |
| June 30, 2018 | 2.987M |
| March 31, 2018 | 2.415M |
| December 31, 2017 | 3.826M |
| September 30, 2017 | 3.399M |
| June 30, 2017 | 3.072M |
| March 31, 2017 | 3.524M |
| December 31, 2016 | 3.561M |
| September 30, 2016 | 5.513M |
| June 30, 2016 | 5.075M |
| March 31, 2016 | |
| December 31, 2015 | 0.686M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 9.04B |
| Labcorp Holdings, Inc. | 9.909B |
| OPKO Health, Inc. | 645.29M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 566.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.089B |
| Shareholders Equity (Quarterly) | 1.002B |
| Debt to Equity Ratio | 0.0096 |
| Current Ratio | 6.338 |
| Net Debt Paydown Yield | -0.05% |